Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Abbreviations DM2: diabetes mellitus type 2 GCR: glucagon receptor GIPR: glucose-dependent insulinotropic peptide receptor GLP-1a: glucagon-like peptide-1 analogues HbA1c: glycated hemoglobin HCC: hepatocellular carcinoma MRI-PDFF: Magnetic Resonance Imaging-Proton Density Fat Fraction NAFLD: Non-alcoholic fatty liver disease NASH: non-alcoholic steatohepatitis NCT: National Clinical Trial number PPAR: Peroxisome Proliferator-Activated Receptor RCT: randomized clinical trial SGLT-2i: sodium-glucose co-transporter-2 inhibitors Declarations Funding None to declare
Watch for any unusual signs, like swelling or redness that lasts too long
Rare genetic forms of obesity: from gene to therapy
The FY2026 April 1 ICD-10-CM release applies to healthcare services provided from April 1, 2026 through September 30, 2026
At the beginning of his recent Vanderbilt Discovery Lecture on glucagon-like peptide-1 (GLP-1) receptor agonists, Daniel Drucker, MD, joked that the title for his presentation could be What I still dont understand about how GLP-1 works. Drucker is a pioneering scientist whose research contributed to the development of the blockbuster GLP-1 medicines used to treat diabetes and obesity
Convenient Location: Easily accessible at 3621 Ambassador Caffery Pkwy, Suite 100, Lafayette, LA 70503
